Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
3 Must-Know Tricks for Investing in Big Pharma Stocks
05:46am, Friday, 08'th Sep 2023
Pharma companies often have detailed plans for when new revenue will occur. They also sometimes describe periods when sales will be shrinking.
Pfizer Inc. (PFE) Citi's 18th Annual BioPharma Conference (Transcript)
06:02pm, Thursday, 07'th Sep 2023
Pfizer Inc. (NYSE:PFE ) Citi's 18th Annual BioPharma Conference September 7, 2023 10:30 AM ET Company Participants Mikael Dolsten - Chief Scientific Officer & President, Pfizer Research & Development
Could Pfizer Stock Help You Become A Millionaire?
09:15am, Thursday, 07'th Sep 2023
Pfizer has accumulated tens of billions in free cash flow over the past couple of years. The company is turning to acquisitions to help bolster its top line and offset losses in exclusivity.
3 Stocks to Buy For the COVID Resurgence
08:44am, Thursday, 07'th Sep 2023
The cold and flu season is upon us, but COVID-19 cases and hospitalizations have also increased recently. The Centers for Disease Control (CDC) will be voting on updated COVID-19 vaccines at a meeting
Pfizer, Valneva announce 'positive' results for Lyme disease vaccine candidate booster shot
01:22am, Thursday, 07'th Sep 2023
Pfizer and French pharmaceutical peer Valneva announced on Thursday that a phase 2 study for its VLA15 Lyme disease vaccine candidate showed a "strong immune response" in both children and adolescents
Dow Slides 200 Points As Disney, Pfizer, Walgreens Stocks Sink To 52-Week Lows
04:02pm, Wednesday, 06'th Sep 2023
Also weighing on stocks Wednesday was a roughly $240 billion wipeout in market capitalization for the Apple-led coalition of seven large tech companies who have buoyed 2023's gains.
Pfizer says updated COVID shot generated strong reaction vs new variant in mice
02:10pm, Wednesday, 06'th Sep 2023
Pfizer on Wednesday said the updated Pfizer-BioNTech COVID-19 vaccine expected to be used this fall elicited a strong antibody response against the highly mutated BA.2.86 subvariant of the coronavirus
UK joins EU in approving XBB.1.5 jab from Pfizer-BioNTech, but others subvariants are emerging
09:47am, Wednesday, 06'th Sep 2023
An updated Covid-19 vaccine made by Pfizer Inc (NYSE:PFE) and BioNTech has been approved by the UK medical regulator, amid a rise in new variants and subvariants of the virus. The new Pfizer-BioNTech
3 Forever Stocks to Buy With $100
02:00pm, Tuesday, 05'th Sep 2023
Disney and Pfizer may be about to enter new phases of growth -- and they are trading at bargain valuations. Coca-Cola offers the advantages of brand strength and a dividend you can count on.
UK regulator approves updated Pfizer-BioNTech COVID vaccine
10:08am, Tuesday, 05'th Sep 2023
The UK drug regulator said on Tuesday it has approved an updated COVID-19 vaccine by Pfizer and its German partner BioNTech that targets only the Omicron XBB.1.5 subvariant.
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
10:00am, Tuesday, 05'th Sep 2023
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a discussion with Angela Hwang, Chief Commercial Officer, President, Glob
Coronavirus Cases Are on the Rise -- Should You Buy Vaccine Stocks?
05:30am, Tuesday, 05'th Sep 2023
The U.S. is reporting increases in positive coronavirus tests and in coronavirus hospitalizations. Pfizer, Moderna, and Novavax are readying their updated vaccines for the fall vaccination season.
Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It
10:31am, Monday, 04'th Sep 2023
Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
3 Reasons to Buy Pfizer Stock
08:30am, Sunday, 03'rd Sep 2023
Pfizer is currently pumping out plenty of brand-new approvals this year. The company's latest acquisition should strengthen its oncology business.
Here's Why the Next 4 Months May Be Critical for Pfizer
05:30am, Friday, 01'st Sep 2023
Pfizer reported record-high revenue in 2022, but the company doesn't yet know what to expect from its coronavirus products in the coming years. Management has said the coronavirus vaccine market may f
